// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Outcomes following implementation of an enhanced recovery programme in liver surgery: 6-year experience

E. Martinou - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Enhanced recovery program after OPEN and laparoscopic liver resection: may IT enhace the advantages offered by the minimally invasive approach?

F. Giovinazzo - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evolution of laparoscopic hepatectomy in the surgical management of liver disease

M. Baltatzis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Short-term outcomes of laparoscopic versus open left lateral sectionectomy: an international propensity score matched study

R. Fichtinger - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Laparoscopic versus open liver resection of right posterior segments – A single centre comparative study

M. Papoulas - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Surgical resection of hepatocellular carcinoma among patients with cirrhotic and non-cirrhotic background liver: a comparative analysis of post-operative outcomes

B. Dasari - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Surgical resection of gall bladder cancer among patients presenting with jaundice: a systematic review and meta-analysis

B. Dasari - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gallbladder cancer

N/A

Perioperative outcomes of 857 consecutive radiofrequency-assisted liver resections

I. Reccia - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Immediate recognition of iatrogenic vascular injuries allows for emergency reconstruction in major liver resections

M. Kalisvaart - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Minimally invasive ALPPS-is it the future?

C. Delimpalta - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Biloma following hepatic artery embolisation (HAE) for major liver trauma at the alfred - is early endoscopic or surgical intervention required?

R. Lahiri - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Trauma

N/A

Role of ALT, bilirubin, alkaline phosphatase and CRP on predicting gallstone pancreatitis – a single centre experience

U. Mathuram Thiyagarajan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Pancreatitis

Alkaline phosphatase

Predictive value of raised serum lipase on diagnosing acute pancreatitis – a single centre experience

U. Mathuram Thiyagarajan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Pancreatitis

lipase

Varying inflammatory responses in gallstone pancreatitis versus non-biliary pancreatitis – an interesting finding

U. Mathuram Thiyagarajan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Pancreatitis

N/A

Measurement of indicator genes using cDNA amplification by polyadenylic acid RT-PCR (Poly A RT-PCR) using paired samples from tissue and ductal juice during pancreaticoduodenectomy

S. Sanyal - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Intraductal papillary mucinous neoplasm

N/A

Does blood group affect survival following pancreatoduodenectomy for periampullary malignancy?

K. Khalil - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Gemcitabine-based neoadjuvant treatment in borderline resectable pancreatic ductal adenocarcinoma: a systematic review and meta-analysis of individual patient data

F. Giovinazzo - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

Gemcitabine

Systemic adjuvant and neoadjuvant chemotherapy in modern pancreatic cancer treatment: a systematic review and meta-analysis

K. Rangarajan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

N/A

Root of mesentery and small bowel tumours also the domain of HPB surgeons: a single UK centre outcome

D. Gumaa - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Outcomes of neoadjuvant therapy for locally advanced pancreatic adenocarcinoma: an intention to treat analysis with comparison to patients with resectable and borderline resectable disease

S.K. Kamarajah - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

N/A

Copyright © 2026. QuantiNova All rights reserved